The UK Competition and Markets Authority has given McCormick and Unilever until 18 November to propose remedies for their food deal. The regulator’s 11 November decision identified two areas of concern: the supply of dry recipe mixes and dry sauces to UK retailers.

The CMA said the planned acquisition of Unilever Foods would bring together the two biggest branded suppliers in both categories. McCormick sells Schwartz mixes and sauces in the UK. Unilever’s food brands include Knorr and Colman’s.

The two categories matter separately. A chilli con carne sachet helps make the meal, while a dry parsley sauce is typically served over it. The CMA identified Maggi as a competitor in mixes and Bisto in sauces. It found that those brands and supermarket own label offered only limited competitive pressure on the merging businesses.

Mustard was also reviewed. The regulator found no competition concern there because supermarkets reported that shoppers generally did not treat French’s American mustard, Colman’s English mustard and Maille’s French mustard as substitutes.

Unilever told Reuters that it had decided to sell the Colman’s brand and assets to address potential competition concerns. The company’s statement does not establish which products or assets would form part of a formal remedy, or whether the CMA would accept it.

For category buyers, the distinction matters because the regulator is assessing competition in two specific dry categories. The strength of an alternative depends on which lines it can supply at scale, what pack sizes it can support and how quickly it can take on promotional volumes. The CMA said limited supermarket shelf space and established ranges made it hard for new suppliers to enter or expand.

Retailers mapping private label sauce suppliers should check whether a manufacturer can supply dry blends rather than assuming that a wet sauce producer can switch formats. Procurement teams can also check which lines rely on a single supplier and whether alternatives have already passed quality and allergen checks. The decision does not itself change current listings or supply terms.

The next milestone is 18 November. The CMA will refer the deal for a full investigation if the companies offer no remedy or if the regulator finds their proposal insufficient.

Editor’s note: This report is based on the CMA’s phase one decision summary dated 11 November 2026 and Unilever’s response to Reuters.